The gemaker team worked with a leading Australian university to evaluate the feasibility of creating a health and medical facility and translation hub based at the university with a future value in excess of $15m. As part of the project, gemaker undertook initial market research to identify the potential segments of the highest value and the […]
Curtin University engaged gemaker to conduct an independent commercialisation assessment of a software-based diagnostic tool. Following meetings with the Curtin Researcher & Commercialisation Teams, gemaker conducted desktop research and target customer interviews to develop a short-form report including a high-level summary of the market and competitors, value proposition, solution delivery options, team capability and capacity, […]
gemaker helped give RMI Oceania a modern and professional presence as they publicly launched their Robotic Ultrasound Imaging System (RUIS). Tasks included:
gemaker was engaged to guide and facilitate Western Sydney University’s (WSU) development of three new strategic research initiatives (SRIs): The gemaker team delivered a raft of services to meet WSU’s needs, including:
The gemaker team helped the Ingham Institute to apply for a $2M grant from the Australian Government’s Medical Research Future Fund. COVID-19 can damage the heart and cause cardiac arrhythmias, increasing the risk of stroke and heart failure. There are no validated models or guidelines for remotely monitoring the cardiac health of COVID-19 survivors who […]
Bionic Vision Technologies’ (BVT) Vibrosight is a non-invasive, hands-free, wearable device giving vision-impaired people independent mobility. gemaker secured stories across several networks, including Nine News, NewsBreak (20M+ readers), WomenLoveTech and ABC Radio, and our grant writing team prepared a CRC-P application.
The gemaker team worked closely with the Australian Precision Medicine Enterprise (APME) partners to prepare a successful application for $23M funding from the Australian Government’s Modern Manufacturing Initiative (MMI) to establish a new theranostics capability in Australia. Theranostics is precision medicine at the molecular level, using a radioactive imaging diagnostic with a therapeutic radioactive drug, […]